CONTRA-MAB
Live / Applied — New application — not yet assigned to an examiner (as of 17 Mar 2026)
What this means for you
Not registered yet, but its 17 Mar 2026 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99706801
- Mark type
- Stylized text
- Filed
- 17 Mar 2026
- Attorney of record
- Andrew D. Skale
Goods and services
- Class 042 — Scientific and technological services: Discovery and development of engineered modular protein formats; Discovery and development of new drug candidate material; Research and development of therapeutic antibodies and pharmaceuticals, and research and development of technology in the field of therapeutic antibodies and pharmaceuticals; Discovery, research, and development services in the field of pharmaceutical preparations and substances; Discovery, research, and development of therapeutic antibodies and pharmaceuticals; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Pharmaceutical, therapeutic, and diagnostic drug discovery services; Medical research in the nature of engineered modular protein formats
Owner
- INHIBRX BIOSCIENCES, INC., La Jolla, CA, US
Prior registrations
Prosecution history
- 17 Mar 2026 — APPLICATION FILING RECEIPT MAILED
- 17 Mar 2026 — NEW APPLICATION ENTERED